|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Fall Managed Care Forum
Nov. 13-14, 2014
Las Vegas Nevada
Click here to visit the conference website.
Click Here to view the Journal of Managed Care Medicine
Click Here to view our Complimentary Online CME/CEU Webcasts
Journal of Managed Care Medicine new website released
The Journal of Managed Care Medicine (JMCM) has released its new website at www.jmcmpub.org. The website features current issues, past issues, supplements and much more. Be sure to visit the website for updates on the latest topics in managed care medicine.
If you are interested in advertising on the website or in JMCM, please click here.
| Share this article:
Fall Managed Care Forum 2014
The Fall Forum will feature the first Annual Innovation Awards for the NAMCP Medical Directors Institute, AAMCN and AAIHDS. If you are interested in applying for this award, please contact Katie Eads at email@example.com or 804-527-1905 and we will send you an application.
The Fall Forum will be held Nov., 12-13, 2014 at the Bellagio Resort in Las Vegas, Nevada for medical directors, nurses and administrators.
The Forum features up-to-date, useful information on the ACA and healthcare changes, trends and how to improve patient outcomes.
Click here to see the agenda, speakers, register and for more information on the conference.
Click Here to visit the Population Health Management Institute
Solidarity vs. solitary: Why collaboration means better healthcare
By Karen R. Thomas
Historically, healthcare has been adept at achieving highly focused and specialized solutions. However, some critics consider the segmented way that healthcare establishments have operated in the past far too solitary for today's wider and more inclusive care goals. Collaboration within the healthcare community used to be an often-discussed but seldom-practiced idea. Today, with a greater sense of solidarity within the healthcare industry, home care software companies and telehealth providers are some of the most sought-after collaborators being invited to the table.
Health law has caveat on renewal of coverage
The New York Times
Millions of consumers will soon receive notices from health insurance companies stating that their coverage is being automatically renewed for 2015, along with the financial assistance they received this year from the federal government.
But consumer advocates and insurers say they see a significant potential for confusion because some of the information will be out of date and misleading on costs and other aspects of coverage.
Growing burden of employer-provider healthcare has accelerated under Obamacare
There’s been a fierce debate over whether Obamacare has increased health insurance premiums. Progressives have argued Obamacare is working due to modest projected premium increases on the exchanges for 2015. Conservatives have retorted that “there can be no doubt that healthcare today is more costly than it would have been without Obamacare.”
ACCOUNTABLE CARE ORGANIZATIONS
Health literacy: A key ingredient for ACO success
Are your accountable care organization policies developed from a perspective that takes the degrees of health literacy of your covered lives into account? Does your ACO proactively foster an environment in which patients, regardless of degree of literacy, feel comfortable seeking help and asking questions?
Are ACOs solution or piece of healthcare fad diet?
Physicians News Digest
It’s no secret that the healthcare system in this country needs to go on a diet when it comes to costs. Currently, healthcare consumes almost 20% of the U.S. economy. In 1960, back when our healthcare system was more “fit and trim,” it only accounted for 5 percent of the U.S. economy. If this trend continues, healthcare will make up 100 percent of the U.S. economy by the time my children would qualify for Medicare. Needless to say, it’s time to go on a diet!
What does a good day mean for your patients?
To find out how to feature your company in the NAMCP eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
FDA: NEW TREATMENTS & TECHNOLOGY
FDA panel recommends approval of Novo Nordisk obesity treatment
The Wall Street Journal
Novo Nordisk said a U.S. Food and Drug Administration advisory panel recommended approval of the Danish drug maker's injectable diabetes drug as a treatment to fight obesity.
The diabetes treatment, known as Victoza, will be marketed as Saxenda if it is approved as an obesity drug.
Novo Nordisk said the advisory panel voted 14 to 1 in favor of approval.
Orexigen wins US FDA approval for weight loss pill
Orexigen Therapeutics Inc. won U.S. approval for its obesity drug, making Contrave the third weight loss pill to hit the market in the last two years. The shares fell the most in three months as regulators required notice of potential health complications from the treatment.
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute
Researchers develop new type of genetic test for identifying developmental disorders
A large team of researchers with members from a host of countries across the globe has conducted an exhaustive study that has resulted in the development of a new genetic test to help identify development disorders in children. In their paper published in the journal Nature Genetics, the researchers describe their study, the results they found and what it might mean for children with development disorders in the near future.
New gene variants for prostate cancer identified
HealthDay News via U.S. News & World Report
An international team of scientists has identified 23 new genetic variants linked to a greater risk for prostate cancer.
Although more research is needed, the researchers said their findings, which bring the total number of common gene variants associated with prostate cancer to 100, could help doctors diagnose the disease earlier and could lead to the development of new treatments.
Click Here to visit the Center for Preventive Health and Lifestyle Medicine
US works to step up Ebola aid, preps hospitals for potential patients
The Associated Press via Fox News
The American strategy on Ebola is two-pronged: Step up desperately needed aid to West Africa and, in an unusual step, train U.S. doctors and nurses for volunteer duty in the outbreak zone. At home, the goal is to speed up medical research and put hospitals on alert should an infected traveler arrive.
Millions of kids prescribed unnecessary antibiotics
HealthDay News via CBS News
Pediatricians prescribe antibiotics about twice as often as they're actually needed for children with ear and throat infections, a new study indicates.
More than 11 million antibiotic prescriptions written each year for children and teens may be unnecessary, according to researchers from University of Washington and Seattle Children's Hospital.
Click Here to visit the Oncology Institute
Risks of breast cancer screening in women 70-plus
Including women ages 70 and over in a national breast cancer screening program does not lead to a large decline in advanced cases, and it may have certain consequences, a Dutch study says.
In the Netherlands, the upper age limit for getting screened was extended from 69 to 75 in 1998. That allowed researchers from the Leiden University Medical Centre to look at the impact on diagnoses of late-stage cancers in this upper age group.
Decades after nuclear test, US studies cancer fallout
The Wall Street Journal
Nearly 70 years after the U.S. conducted the world's first atomic-bomb test here in the New Mexico desert, federal researchers are slated to visit the state this month to begin studying whether some residents developed cancer due to the blast.
Click Here to visit the Behavioral Health Institute
Schizophrenia 'made up of 8 specific genetic disorders'
Medical News Today
Past studies have indicated that rather than being a single disease, schizophrenia is a collection of different disorders. Now, a new study by researchers at Washington University in St. Louis claims the condition consists of eight distinct genetic disorders, all of which present their own specific symptoms.
"A protein called Kindlin-3 drives breast cancer cells to migrate throughout the body. Inhibiting Kindlin-3 functions with new drugs could prevent the spread of breast cancer, according to the Cleveland Clinic's Lerner Research Institute."
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063